🇺🇸 FDA
Patent

US 8609703

Modulators of ATP-binding cassette transporters

granted A61KA61K31/404A61K31/4439

Quick answer

US patent 8609703 (Modulators of ATP-binding cassette transporters) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/404, A61K31/4439, A61K31/454, A61K31/4725